Acquisition of US-based SPEware Corporation further expands Tecan’s dedicated solutions offering into new market segment

SPEware to become part of Tecan’s Life Sciences Business, leveraging Tecan’s global presence and strong position in mass spectrometry sample preparation automation platforms

Over 70% of SPEware’s revenues are generated from smart consumables, thus increasing Tecan’s overall recurring revenues

Base consideration of USD 50.0 million (CHF 49.0 million)

Valuation representing approximately three times expected fiscal year 2016 sales of SPEware; SPEware’s EBITDA margin exceeds Tecan’s

Transaction anticipated to be immediately accretive to earnings per share before transaction-related amortization

Closing of the transaction expected within the coming weeks

Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) announced today the acquisition of US-based SPEware Corporation (SPEware) to further expand Tecan’s dedicated